SCHEMBL1897012

SCHEMBL1897012

O=C(O)NCC(=O)C(Cc1ccccc1)[N+](=O)[O-]

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CPA1 P15085 6/20 0.45
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MME P08473 4/20 0.39
ALDH1A1 P00352 2/20 0.39
ACE P12821 2/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPT P10636 1/20 0.39
ECE1 P42892 1/20 0.39
BLM P54132 1/20 0.39
NPEPPS P55786 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11856157 0.82 CPA1 (0.51) CPA1CYP1A2MEN1KMT2A
SCHEMBL2555562 0.79 CPA1 (0.59) CPA1CYP1A2HSD17B10
SCHEMBL11081087 0.77 CPA1 (0.53) CPA1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL1305447 0.76 CPA1 (0.51) CPA1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL28007680 0.74 MDM2 (0.58) CPA1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL6948627 0.74 CYP1A2 (0.44) NPC1RAB9ASMN1; SMN2CYP1A2MEN1
SCHEMBL27623586 0.72 CPA1 (0.47) CPA1CYP1A2
SCHEMBL28210499 0.72 CPA1 (0.47) CPA1NPC1TP53RAB9ASMN1; SMN2
SCHEMBL16061774 0.70 MEN1 (0.45) NPC1TP53RAB9ASMN1; SMN2CYP1A2
SCHEMBL714764 0.68 CPA1 (0.53) CPA1NPC1TP53RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011061675-A1 PROCESS FOR ENANTIOSELECTIVE PREPARATION OF NITROKETONE, AN INTERMEDIATE OF PROTEASE INHIBITORS PIRAMAL HEALTHCARE LIMITED (IN) 2011-05-26 WO disclosed